Transgenic Sciences Is Metamorphosing

Transgenic Sciences lnc.—a startup that is banking on a future where chickens lay eggs that contain pharmaceutical proteins, pigs grow up with more meat and less fat than-they do now, and mice produce beneficial human proteins in their milk—is undergoing a few transformations itself this month. Led by new CEO James Sherblom, formerly of Genzyme Corp., the firm aims to raise $5 million and augment its scientific staff as a result of the initial public offering it expects to complete in the next few weeks. If all goes according, to plan, the Worcester, Mass. - based company will add about six molecular biologists to its current staff of four full-time and four part-time researchers. The two-year-old startup also hopes to expand the scope of its research beyond the cooperative research agreements it has involving transgenic species. (The transgenic chicken project is being conducted with Tufts’ School...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?